TE_38968
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSg7 |
|---|---|
| TE superfamily | Alu |
| TE order | SINE |
| Gene | OFD1P2Y |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 5.26 |
| Counts of samples | TCGA_tumor:13; TCGA_normal:0; GTEx:2 |
| TSS | chrY(-):18087389 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38968.1 | OFD1P2Y | Chimeric | Non-coding | Non-coding | chrY(-):18080809,18080829,18082473,18082540,18083645,18083718,18085556,18085674,18087247,18087390 |
| teRNA_38968.2 | OFD1P2Y | Chimeric | Non-coding | Non-coding | chrY(-):18080809,18080829,18082473,18082540,18083645,18083718,18087247,18087390 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
